Search - tctmd.com

Displaying 801 - 820 of 1184

Sort: Relevancy | Date

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from Grayscale and VH-IVUS

Presenter: Akiko Maehara

October 25, 2012

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from NIRS

Presenter: James Goldstein

October 25, 2012

Presentation TCT 2012

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

Presenter: Gary Mintz

October 25, 2012

Presentation TCT 2012

IVUS Assessment of Stent Thrombosis and Restenosis

Presenter: Soo-Jin Kang

October 25, 2012

News Industry News

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

October 25, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

News Conference News TCT 2012

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

Presentation TCT 2012

Stent Thrombosis Results from a Registry in 18,334 Patients

Presenter: Tomohisa Tada

October 24, 2012

Presentation TCT 2012

Late Bare Metal Stent Thrombosis in the Light of OCT: Management Options?

Presenter: Pasi Karjalainen

October 24, 2012

Presentation TCT 2012

DESERT: Final Analysis of the Clinical and Angiographic Predictors of Stent Thrombosis from a Large, Multicenter Registry

Presenter: Ron Waksman

October 24, 2012

Presentation TCT 2012

Case 2: Peri- and Post-Procedural Management of the Patient with Stent Thrombosis

Presenter: Sorin Brener

October 24, 2012

Presentation TCT 2012

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

Presenter: C. Michael Gibson

October 24, 2012

Presentation TCT 2012

ADAPT-DES IVUS Substudy: Utility of IVUS in Delineating the Mechanism of and Preventing Stent Thrombosis

Presenter: Akiko Maehara

October 24, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Industry News

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

October 24, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

News Conference News TCT 2012

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

October 24, 2012

News Conference News TCT 2012

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

October 24, 2012

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

Advertisement

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from Grayscale and VH-IVUS

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from NIRS

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

IVUS Assessment of Stent Thrombosis and Restenosis

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Stent Thrombosis Results from a Registry in 18,334 Patients

Late Bare Metal Stent Thrombosis in the Light of OCT: Management Options?

DESERT: Final Analysis of the Clinical and Angiographic Predictors of Stent Thrombosis from a Large, Multicenter Registry

Case 2: Peri- and Post-Procedural Management of the Patient with Stent Thrombosis

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

ADAPT-DES IVUS Substudy: Utility of IVUS in Delineating the Mechanism of and Preventing Stent Thrombosis

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content